| 000 | 02966nam a2200613 i 4500 | ||
|---|---|---|---|
| 999 |
_c279348 _d279348 |
||
| 001 | on1078924440 | ||
| 003 | OCoLC | ||
| 005 | 20190311082853.0 | ||
| 007 | he bmb024bbca | ||
| 008 | 181214s2018 dcu b f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _cPTL _dGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a1020-B (MF) | ||
| 086 | 0 | _aY 4.J 89/1:115-27 | |
| 088 | _aSerial no. 115-27 (United States. Congress. House. Committee on the Judiciary) | ||
| 099 | _aY 4.J 89/1:115-27 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bHouse. _bCommittee on the Judiciary. _bSubcommittee on Regulatory Reform, Commercial and Antitrust Law, |
|
| 245 | 1 | 0 |
_aAntitrust concerns and the FDA approval process : _bhearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017. |
| 246 | 3 | _aAntitrust concerns and the Food and Drug Administration approval process | |
| 264 | 1 |
_aWashington : _bU.S. Government Publishing Office, _c2018. |
|
| 300 |
_aiv, 51 pages ; _c24 cm |
||
| 336 | _btxt | ||
| 337 |
_bh _2rdamedia |
||
| 338 |
_bhe _2rdacarrier |
||
| 500 | _aShipping list no.: 2018-0202-M. | ||
| 500 | _a"Serial no. 115-27." | ||
| 500 | _aCRDP Program record. | ||
| 533 |
_aMicrofiche. _b[Washington, D.C.] : _cU.S. Government Printing Office, _d[2018] _e1 microfiche : negative. |
||
| 776 | 0 | 8 |
_iOnline version: _aUnited States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. _tAntitrust concerns and the FDA approval process _w(OCoLC)1042073861 |
| 776 | 0 | 8 |
_iPrint version: _aUnited States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. _tAntitrust concerns and the FDA approval process _w(OCoLC)1042073889 |
| 050 | 4 |
_aKF27 _b.J874 2017h |
|
| 610 | 1 | 0 |
_aUnited States. _bFood and Drug Administration _xRules and practice. |
| 610 | 1 | 7 |
_aUnited States. _bFood and Drug Administration. _2fast |
| 650 | 0 |
_aDrugs _zUnited States _xTesting. |
|
| 650 | 0 |
_aDrug approval _zUnited States. |
|
| 650 | 0 |
_aDrugs _xSafety regulations _zUnited States. |
|
| 650 | 0 |
_aMedical instruments and apparatus _xSafety regulations _zUnited States. |
|
| 650 | 0 |
_aGeneric drugs _zUnited States. |
|
| 650 | 0 |
_aCompetition _zUnited States. |
|
| 650 | 0 |
_aAntitrust law _zUnited States. |
|
| 650 | 7 |
_aAntitrust law. _2fast |
|
| 650 | 7 |
_aCompetition. _2fast |
|
| 650 | 7 |
_aDrug approval. _2fast |
|
| 650 | 7 |
_aDrugs _xSafety regulations. _2fast |
|
| 650 | 7 |
_aDrugs _xTesting. _2fast |
|
| 650 | 7 |
_aGeneric drugs. _2fast |
|
| 650 | 7 |
_aMedical instruments and apparatus _xSafety regulations. _2fast |
|
| 651 | 7 |
_aUnited States. _2fast |
|
| 655 | 7 |
_aLegislative hearings. _2lcgft |
|
| 655 | 7 |
_aLegislative hearings. _2fast |
|
| 655 | 7 |
_aRules. _2fast |
|
| 942 |
_2sudocs _c8 |
||